Vijaypd Ceutical Ltd
Incorporated in 1971, Vijaypd Ceutical Ltd is engaged in wholesale Distribution of pharmaceutical products.[1]
- Market Cap ₹ 153 Cr.
- Current Price ₹ 78.2
- High / Low ₹ 114 / 38.2
- Stock P/E 30.5
- Book Value ₹ 26.9
- Dividend Yield 0.00 %
- ROCE %
- ROE 9.54 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 2.91 times its book value
- Earnings include an other income of Rs.4.11 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Industrials Capital Goods Electrical Equipment Heavy Electrical Equipment
Part of Nifty SME Emerge
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Sales |
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2026 | |
|---|---|
| 100 | |
| Sales growth | |
| 96 | |
| Operating Profit | 5 |
| OPM % | 4.7% |
| 4 | |
| Interest | 2 |
| Depreciation | 1 |
| Profit before tax | 6 |
| Tax % | 23% |
| 5 | |
| EPS in Rs | 2.56 |
| Dividend Payout % | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 77% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 10% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2026 | |
|---|---|
| Equity Capital | 20 |
| Reserves | 33 |
| 37 | |
| 10 | |
| Total Liabilities | 100 |
| 9 | |
| CWIP | 2 |
| Investments | 0 |
| 89 | |
| Total Assets | 100 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2026 | |
|---|---|
| -9 | |
| -13 | |
| 28 | |
| Net Cash Flow | 6 |
| Free Cash Flow | -11 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | -157% |
Ratios
Consolidated / View Standalone
| Mar 2026 | |
|---|---|
| Debtor Days | 111 |
| Inventory Days | 50 |
| Days Payable | 33 |
| Cash Conversion Cycle | 129 |
| Working Capital Days | 57 |
| ROCE % |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Number of Customers customers ・Standalone data |
|
||
| Number of Permanent Employees employees ・Standalone data |
|||
| Number of Suppliers/Manufacturers suppliers ・Standalone data |
|||
| Revenue from Repeat Customers % of total revenue ・Standalone data |
|||
| Top 10 Customer Revenue Concentration % of total revenue ・Standalone data |
|||
| Attrition Rate % ・Standalone data |
|||
| Number of SKUs (Stock-Keeping Units) SKUs ・Standalone data |
|||
| Warehouse Area sq ft ・Standalone data |
|||
Extracted by Screener AI
Documents
Announcements
-
Outcome of Board Meeting
- Board approved main object clause alteration and postal ballot steps on October 26, 2026.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
- Regulation 74(5) depository certificate filed for quarter ended 30 September 2026.
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
- Vijaypd Ceutical says corporate governance report not applicable for quarter ended 30 September 2026.
-
General Updates
- Vijaypd Ceutical appointed Finportal Investments as IR agency effective 5 October 2026.
-
Shareholders meeting
- Vijaypd Ceutical reported 2nd AGM voting results on Oct 2, 2026; 10 resolutions passed.
Business Overview:[1]
VCL is engaged in the distribution and supply business across the pharmaceutical, wellness, and fast-moving consumer goods sectors. It operates as a representative, dealer, agent, stockist, supplier, trader, and packer, providing
a comprehensive range of products and services.